Left Atrial Appendage Closure for Stroke Prevention is Safe and Effective in Selected Patients with Atrial Fibrillation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-06-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.19102/icrm.2016.070605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation.

  2016cited by this paper
• Left atrial appendage exclusion

  2016cited by this paper
• Left atrial appendage isolation using percutaneous (endocardial/epicardial) devices: Pre-clinical and clinical experience.

  2016cited by this paper
• Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation.

  2016influential reference
• Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin

  2016influential reference
• Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.

  2016cited by this paper
• Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices.

  2015cited by this paper
• Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.

  2015cited by this paper
• Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device

  2015influential reference
• Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation

  2015cited by this paper
• Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Therapy In Italy And Spain.

  2015cited by this paper
• Left atrial appendage occlusion debate revisited.

  2015cited by this paper
• Left Atrial Appendage Closure Reduces the Incidence of Postoperative Cerebrovascular Accident in Patients Undergoing Cardiac Surgery.

  2015influential reference
• Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF: Warfarin Versus NOACs Versus LAA Closure.

  2015influential reference
• Left Atrial Appendage Ligation and Ablation for Persistent Atrial Fibrillation: The LAALA-AF Registry.

  2015cited by this paper
• Atrial fibrillation: A major risk factor for cognitive decline.

  2015cited by this paper
• The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.

  2015cited by this paper
• Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design.

  2015influential reference
• Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation

  2015cited by this paper
• Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates.

  2014cited by this paper
• Faculty Opinions recommendation of A controlled trial of renal denervation for resistant hypertension.

  2014cited by this paper
• Anatomic analysis of the left atrial appendage after closure with the LARIAT device.

  2014influential reference
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

  2014cited by this paper
• Percutaneous left atrial appendage closure: procedural techniques and outcomes.

  2014influential reference
• Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

  2014cited by this paper
• Warfarin-Induced Skin Necrosis

  2014cited by this paper
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

  2014cited by this paper
• The effects of LAA ligation on LAA electrical activity.

  2014cited by this paper
• Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application.

  2014cited by this paper
• Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

  2013cited by this paper
• Left atrial appendage closure

  2013influential reference
• Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial

  2013cited by this paper
• The cognitive impact of atrial fibrillation.

  2013cited by this paper
• Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function.

  2013influential reference
• Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.

  2013cited by this paper
• Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.

  2013cited by this paper
• Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.

  2013influential reference
• Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation.

  2013cited by this paper
• Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.

  2011cited by this paper
• A Patient's Guide to Taking Dabigatran Etexilate.

  2011cited by this paper
• Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study

  2010cited by this paper
• Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin

  2009cited by this paper
• Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography.

  2008influential reference
• Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.

  2008influential reference
• Left Atrial Appendage Exclusion for Stroke Prevention in Patients With Nonrheumatic Atrial Fibrillation

  2007cited by this paper
• Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry.

  2006cited by this paper
• Systematic overview of warfarin and its drug and food interactions.

  2005cited by this paper
• Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.

  2004cited by this paper
• Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin

  2004cited by this paper
• Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients

  2004cited by this paper
• Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study.

  2000cited by this paper
• Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting.

  2000cited by this paper
• Left atrial appendage: structure, function, and role in thromboembolism

  1999influential reference
• Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy

  1997cited by this paper
• Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.

  1996cited by this paper
• Warfarin-induced changes in procoagulant and anticoagulant proteins.

  1995cited by this paper
• Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

  1991cited by this paper
• Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

  1987cited by this paper
• The Framingham study.

  1976cited by this paper

• No citing papers are available for this paper.